Anticoagulants: Clinical Trials

4 trials for Anticoagulants, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 terminated, 1 withdrawn. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 1, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 11Completed 1

Follow Anticoagulants: new trials by email Literature Review of Anticoagulants trials Research Report on Anticoagulants

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation
Apixaban (Eliquis), Placebo - Venous Malformation, Low Flow, Anticoagulants
Phase 2Not yet recruitingOslo University Hospital202025-02-012024-12-11
HYDROxychloroquine in Syndrome Primary AntiPhospholipid
Plaquenil 200Mg Tablet, Placebo oral tablet - Antiphospholipid Syndrome in Pregnancy, Anticoagulants
Phase 2WithdrawnAssistance Publique - Hôpitaux de Paris2021-07-092026-04-06
Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization
Combination drug - Ischemia, Anticoagulants
Phase 1 / Phase 2CompletedMansoura University15362019-07-032022-07-19
Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.
Rivaroxaban - Aortic Valve Disease, Heart Valve Prosthesis Implantation
Phase 2TerminatedInsel Gruppe AG, University Hospital Bern122012-09-012017-11-17

Narrower conditions

Aortic Valve Disease (1)  ·  Ischemia (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Heart Valve Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Drug Combinations (1)  ·  Hydroxychloroquine (1)  ·  Rivaroxaban (1)  ·  apixaban (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Mansoura University (1)  ·  Oslo University Hospital (1)

Countries

Egypt (1)  ·  France (1)  ·  Norway (1)  ·  Switzerland (1)

Top investigators

Eva Roost, MD (1)  ·  Nshaat A Elsaadany, MSc (1)

Results publications

PMID 31837559